Search research articles
Contact Us
Filters
Showing results (31-40 of 84) with videos related to
Page
of 9
Sort By:
Frontiers in Immunology
|
July 5, 2018
Immune Curbing of Cancer Stem Cells by CTLs Directed to NANOG
Christina Wefers, Gerty Schreibelt, Leon F A G Massuger, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
September 26, 2007
In vivo targeting of antigens to human dendritic cells through DC-SIGN elicits stimulatory immune responses and inhibits tumor growth in grafted mouse models
Anke Kretz-Rommel, Fenghua Qin, Naveen Dakappagari, et al.
Cancer Immunology, Immunotherapy : CII
|
February 2, 2012
Harnessing human plasmacytoid dendritic cells as professional APCs
Jurjen Tel, Anne M van der Leun, Carl G Figdor, et al.
European Journal of Oral Sciences
|
February 1, 2012
Myogenic capacity of muscle progenitor cells from head and limb muscles
Sander Grefte, Mette A R Kuijpers, Anne M Kuijpers-Jagtman, et al.
Biomaterials
|
March 14, 2012
Comparison of antibodies and carbohydrates to target vaccines to human dendritic cells via DC-SIGN
Luis J Cruz, Paul J Tacken, Jeanette M Pots, et al.
Blood
|
December 15, 2005
Long-term engagement of CD6 and ALCAM is essential for T-cell proliferation induced by dendritic cells
Aukje W Zimmerman, Ben Joosten, Ruurd Torensma, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
September 28, 2011
Cytokine profiles in cyst fluids from ovarian tumors reflect immunosuppressive state of the tumor
Refika Yigit, Leon F A G Massuger, Petra L M Zusterzeel, et al.
Journal of Leukocyte Biology
|
December 1, 2006
Relevance of DC-SIGN in DC-induced T cell proliferation
Karlijn Gijzen, Paul J Tacken, Aukje Zimmerman, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 26, 2011
Cytokine analysis as a tool to understand tumour-host interaction in ovarian cancer
Refika Yigit, Carl G Figdor, Petra L M Zusterzeel, et al.
Molecules (Basel, Switzerland)
|
May 15, 2019
ICAM3-Fc Outperforms Receptor-Specific Antibodies Targeted Nanoparticles to Dendritic Cells for Cross-Presentation
Luis J Cruz, Paul J Tacken, Johan M S van der Schoot, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 84) with videos related to
Sort By:
Page
of 9
Frontiers in Immunology
|
July 5, 2018
Immune Curbing of Cancer Stem Cells by CTLs Directed to NANOG
Christina Wefers, Gerty Schreibelt, Leon F A G Massuger, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
September 26, 2007
In vivo targeting of antigens to human dendritic cells through DC-SIGN elicits stimulatory immune responses and inhibits tumor growth in grafted mouse models
Anke Kretz-Rommel, Fenghua Qin, Naveen Dakappagari, et al.
Cancer Immunology, Immunotherapy : CII
|
February 2, 2012
Harnessing human plasmacytoid dendritic cells as professional APCs
Jurjen Tel, Anne M van der Leun, Carl G Figdor, et al.
European Journal of Oral Sciences
|
February 1, 2012
Myogenic capacity of muscle progenitor cells from head and limb muscles
Sander Grefte, Mette A R Kuijpers, Anne M Kuijpers-Jagtman, et al.
Biomaterials
|
March 14, 2012
Comparison of antibodies and carbohydrates to target vaccines to human dendritic cells via DC-SIGN
Luis J Cruz, Paul J Tacken, Jeanette M Pots, et al.
Blood
|
December 15, 2005
Long-term engagement of CD6 and ALCAM is essential for T-cell proliferation induced by dendritic cells
Aukje W Zimmerman, Ben Joosten, Ruurd Torensma, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
September 28, 2011
Cytokine profiles in cyst fluids from ovarian tumors reflect immunosuppressive state of the tumor
Refika Yigit, Leon F A G Massuger, Petra L M Zusterzeel, et al.
Journal of Leukocyte Biology
|
December 1, 2006
Relevance of DC-SIGN in DC-induced T cell proliferation
Karlijn Gijzen, Paul J Tacken, Aukje Zimmerman, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 26, 2011
Cytokine analysis as a tool to understand tumour-host interaction in ovarian cancer
Refika Yigit, Carl G Figdor, Petra L M Zusterzeel, et al.
Molecules (Basel, Switzerland)
|
May 15, 2019
ICAM3-Fc Outperforms Receptor-Specific Antibodies Targeted Nanoparticles to Dendritic Cells for Cross-Presentation
Luis J Cruz, Paul J Tacken, Johan M S van der Schoot, et al.
Page
of 9